Atlantic Urology Medical Group is involved in multiple clinical trials in urology. We are currently enrolling patients in the following clinical trials:
For more information, please contact Lupita Ramirez at 562.595.5977.
Neurogenic Bladder is a condition that can be caused by disease or birth defects including Spina Bifida, which is the most common cause in children. This condition often results in incontinence, bladder infections and increased risk of kidney damage, which significantly impacts daily quality of life.
The purpose of the research study is to test the safety and effectiveness of an investigational drug, oxybutynin chloride topical gel (OXY gel), for Neurogenic Bladder symptoms in children.
Your child may qualify to participate in this research study if they are:
Oxybutynin chloride is approved for the treatment of Neurogenic Bladder symptoms in tablet and liquid form for use by both children and adults as a patch (Oxytrol®) and gel (Gelnique®), for use by adults only.
Research studies are critical to the process of developing safe and effective future treatments and medications and may help other children in the future. If you/your child or someone you know would like more information about this research study, please call to learn more.
To begin searching for clinical trials on Centerwatch now, click here.
To begin searching for clinical trials on ClinicalTrials.gov now, click here.
This is where you can feature something special about the practice, highlight a new service, link to a news article, etc.
It's up to you. You can then add a link, such as to the services page, for them to learn more about the featured item.